# CorriXR Therapeutics, Inc. — Form D/A

CorriXR Therapeutics, Inc. of Newark, DE, a company, filed a Form D amendment with the SEC on 2024-01-29. The offering totals $8.0M, of which $6.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-29
- Form: D/A
- Accession: 0001938281-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $6.5M
- Remaining: $1.5M
- Investors: 4
- Date of first sale: 2022-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-452572

## Issuer

- Name: CorriXR Therapeutics, Inc.
- CIK: 0001938281
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 550 S. College Avenue, Suite 107, Newark, DE, 19713
- Phone: 302-623-5305

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Jeffrey Carper | Director | Newark, DE |
| Eric Kmiec | Director | Newark, DE |
| Deborah Moorad | Director | Newark, DE |
| Janice Nevin | Director | Newark, DE |
| Stella Vnook | Director | Kenmore, NY |
| Jon Brilliant | Executive Officer | Baltimore, MD |
| Eric Kmiec | Executive Officer | Newark, DE |
| Deborah Moorad | Executive Officer | Newark, DE |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-07-15](https://search.stillhousedata.com/formd/0001878646-22-000032) | D | $8.0M | $2.5M |

## More

- [CIK 1938281 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1938281&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001938281-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.